(Q37161861)

English

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas

scientific article published on 03 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas (English)

1 reference

Europe PubMed Central

18 August 2017

20

1 reference

Europe PubMed Central

18 August 2017

6

object named as

Gad Getz

0 references

object named as

Kathryn Alsop

15

0 references

Richard W. Tothill

object named as

Richard Tothill

7

0 references

object named as

Paul Harnett

10

0 references

object named as

Anna deFazio

2

0 references

object named as

David Bowtell

25

0 references

12

object named as

Lars A Akslen

1 reference

Europe PubMed Central

18 August 2017

Matthew Meyerson

24

object named as

Matthew Meyerson

1 reference

Europe PubMed Central

18 August 2017

4

object named as

Craig Mermel

1 reference

Europe PubMed Central

18 August 2017

Rameen Beroukhim

3

object named as

Rameen Beroukhim

1 reference

Europe PubMed Central

18 August 2017

23

object named as

Helga B Salvesen

1 reference

Europe PubMed Central

18 August 2017

author name string

Dariush Etemadmoghadam

1

1 reference

Europe PubMed Central

18 August 2017

Joshy George

5

1 reference

Europe PubMed Central

18 August 2017

Aikou Okamoto

8

1 reference

Europe PubMed Central

18 August 2017

Maria B Raeder

9

1 reference

Europe PubMed Central

18 August 2017

Stephen Lade

11

1 reference

Europe PubMed Central

18 August 2017

Anna V Tinker

13

1 reference

Europe PubMed Central

18 August 2017

Bianca Locandro

14

1 reference

Europe PubMed Central

18 August 2017

Yoke-Eng Chiew

16

1 reference

Europe PubMed Central

18 August 2017

Nadia Traficante

17

1 reference

Europe PubMed Central

18 August 2017

Sian Fereday

18

1 reference

Europe PubMed Central

18 August 2017

Daryl Johnson

19

1 reference

Europe PubMed Central

18 August 2017

William Sellers

21

1 reference

Europe PubMed Central

18 August 2017

Mitsuyoshi Urashima

22

1 reference

Europe PubMed Central

18 August 2017

AOCS Study Group

26

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

3 February 2009

1 reference

Europe PubMed Central

18 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

18 August 2017

15

1 reference

Europe PubMed Central

18 August 2017

1417-1427

1 reference

Europe PubMed Central

18 August 2017

4

1 reference

Europe PubMed Central

18 August 2017

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Drosophila neuroblast asymmetric divisions: cell cycle regulators, asymmetric protein localization, and tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

The resurgence of platinum-based cancer chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Common markers of proliferation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Standard treatment in advanced ovarian cancer in 2005: the state of the art.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Comparative genomic hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Repopulation of cancer cells during therapy: an important cause of treatment failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Cyclin E in normal and neoplastic cell cycles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Cyclin E at the centre of an identity crisis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Primer3 on the WWW for general users and for biologist programmers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

c-myc amplification in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

6 September 2017

Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

14 September 2017

Notch3 gene amplification in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

14 September 2017

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

14 September 2017

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

14 September 2017

Cyclin E deregulation alters the biologic properties of ovarian cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

14 September 2017

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

29 September 2017

High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

3 September 2018

Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

3 September 2018

ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

3 September 2018

Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

3 September 2018

Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

3 September 2018

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670486

3 September 2018

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FISH analysis of BRCA1 copy number in paraffin-embedded ovarian cancer tissue samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplicon profiling reveals cytoplasmic overexpression of MUC1 protein as an indicator of resistance to platinum-based chemotherapy in patients with ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinase-independent function of cyclin E

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19193619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-08-1564

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37161861&oldid=1713221881"